Cargando…
NTRK insights: best practices for pathologists
Since the discovery of an oncogenic tropomyosin-receptor kinase (TRK) fusion protein in the early 1980s, our understanding of neurotrophic tropomyosin-receptor kinase (NTRK) fusions, their unique patterns of frequency in different tumor types, and methods to detect them have grown in scope and depth...
Autor principal: | Hechtman, Jaclyn F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860742/ https://www.ncbi.nlm.nih.gov/pubmed/34531526 http://dx.doi.org/10.1038/s41379-021-00913-8 |
Ejemplares similares
-
Identifying patients with NTRK fusion cancer
por: Solomon, J P, et al.
Publicado: (2019) -
Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion
por: O’Reilly, E M, et al.
Publicado: (2019) -
What is the best way to measure renal fibrosis?: A pathologist's perspective
por: Farris, Alton B, et al.
Publicado: (2014) -
A practical guide to placental examination for forensic pathologists
por: Mittal, Namita, et al.
Publicado: (2019) -
A review of NTRK fusions in cancer
por: Manea, Cristina Alexandra, et al.
Publicado: (2022)